Журнал включен в российские и международные библиотечные и реферативные базы данных
РИНЦ (Россия)
EBSCO
Ulrichsweb

Ulcerative colitis in sisterly practice

DOI: https://doi.org/10.29296/25879979-2021-06-13
Issue: 
6
Year: 
2021

V.V. Skvortsov, G.I. Malyakin, E.A. Goliyeva Volgograd State Medical University, Russian Health Ministry

Ulcerative colitis (UC) is a chronic nonspecific inflammatory disease caused by immune disorders, mental disorders, genetics, and other factors. Its main clinical manifestations are accompanied by abdominal pain, diarrhea, bloody stools, weight loss, etc. A distinctive feature of ulcerative colitis from Crohn’s disease is its limitation by the large intestine, as well as the limited inflammation of the mucous membrane.The disease affects any age group from infants to the elderly, with a maximum incidence rate between the ages of 15 to 30 years and between 50 and 70 years. seriously affects human health and quality of life because of its long duration and repeated attacks, and also has the risk of developing colorectal cancer. The disease violates the quality of life and leads to disability.The article presents the causes of ulcerative colitis, describes the mechanisms for the development of pathological changes in the intestine. Designated principles of patient management, taking into account the severity and tactics of rational drug therapy.

Keywords: 
nonspecific ulcerative colitis
inflammatory bowel disease
gene NOD2/CARD15
PAMP
WCE (Wireless capsule endoscopy)
calprotectin



References: 
  1. Emel'janova V.A., Demidov A.A., Kostenko N.V., Chernysheva E.N. Vospalitel'nye zabolevanija kishechnika: rol' tsitohimicheskoj aktivnosti vnutrikletochnyh fermentov nejtrofilov i monotsitov perifericheskoj krovi v diagnostike. Kubanskij nauchnyj meditsinskij vestnik. 2017; (3): 137-141.
  2. Katorkin S.E., Andreev P.S., Isaev V.R. Jazvennyj kolit - konservativnoe i operativnoe lechenie. Koloproktologija. 2016; S1 (55): 93.
  3. Ramazanova A.H., Mustafin I.G., Odintsova A.H., Nabiullina R.M., Sirazetdinov D.T. Abdulganieva D.I. Vospalitel'nye zabolevanija kishechnika: epidemiologija i razvitie tromboembolicheskih oslozhnenij. PM. 2016; (4): 88-91
  4. Svistunov A.A. Prakticheskaja koloproktologija / A.A. Svistunov, M.A. Osadchuk, A.M. Osadchuk. M.: OOO «Izdatel'stvo «Meditsinskoe informatsionnoe agentstvo», 2016, 336 s.
  5. Skvortsov V.V., Brovchenko I.A., Mkrtychan V.V. Sovremennye aspekty diagnostiki i lechenija nespetsificheskogo jazvennogo kolita. Terapevt. 2019; (3): 8-15.
  6. Sovalkin V.I., Bikbavova G.R., Emel'janova Ju.A. Sovremennyj vzgljad na patogenez i laboratornuju diagnostiku jazvennogo kolita (obzor literatury). Arhiv' vnutrennej meditsiny. 2017; (4): 252-259.
  7. Stepanov Ju.M., Psareva I.V. Rol' biomarkerov v diagnostike hronicheskih vospalitel'nyh zabolevanij kishechnika // Gastroenterologija. 2017; (1): 56-63.
  8. Ma C, Ascoytia C, McCarrier KP, Martin M, Feagan BG, Jairath V. Physicians’ perspectives on cost, safety, and perceived efficacy determine aminosalicylate use in Crohn’s disease. Dig Dis Sci. 2018; (63): 2555–2563.
  9. Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. ACG clinical guideline: ulcerative colitis in adults. Am J Gastroenterol. 2019 Mar;114(3):384-413.
  10. Swift D. Updated UC guideline adds mucosal healing to treatment goal. March 4, 2019. Medscape Medical News.
  11. Vande Casteele N, Feagan BG, Vermeire S, et al. Exposure-response relationship of certolizumab pegol induction and maintenance therapy in patients with Crohn’s disease. Aliment Pharmacol Ther 2018;47:229–237.
  12. Ultiple Infliximab Doses Better for Acute Severe Ulcerative Colitis - Medscape - Feb 01, 2019.
  13. Harbord M, Eliakim R, Bettenworth D, et al. European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: Current Management. J Crohns Colitis. 2017; (11): 769–784.
  14. Skvortsov V.V., Gorbach A.N. Diagnostika i lechenie bolezni Krona. Effektivnaja farmakoterapija. 2019; (2): 64-68.
  15. Kuvaev R., Kashin S., Zav'jalov D. Rol' kolonoskopii v diagnostike displazii i raka tolstoj kishki pri jazvennom kolite. Vrach. 2016, (2): 70-76.
  16. Krylova I. Preparat pentasa v lechenii nespetsificheskogo jazvennogo kolita i bolezni Krona. Vrach. 2014, (1): 35-36.